Epocrates IPO

By MHN Staff May 9, 2011
WLSA Co-Founder, President, CEO Robert McCray By Robert B. McCray, Co-Founder, President and CEO of the Wireless-Life Sciences Alliance (WLSA) The Wireless-Life Sciences Alliance convenes its 6th annual WLSA Convergence Summit in San Diego this week. In 2005 WLSA was the first organization to focus exclusively on the convergence of communications technology and healthcare, based on the founders...
By Brian Dolan February 3, 2011
Three important stories broke on the same day this week: Epocrates went public and raised $86.4 million; Dr. Patrick Soon-Shiong acquired GlowCap-maker Vitality for some unnamed tens of millions of dollars; A stealthy mobile-focused startup named Massive Health launched. Which of these will prove to be the most important longterm? Obviously the Epocrates IPO is a massive boon to mobile health,...
By Brian Dolan February 2, 2011
Medical app publisher Epocrates went public this morning. Along with its selling stockholders, Epocrates raised more than expected: $86.4 million before costs. This is Epocrates third IPO attempt: In 2008 it filed for a $75 million IPO, but withdrew it because of the economic downturn. Last summer Epocrates filed for another $75 million IPO. Apparently, being patient paid off. The newest publicly...
By Brian Dolan October 6, 2010
This week Jeff Tangney, co-founder of one of the (if not the) most popular smartphone medical apps, Epocrates, launched a new mobile-centric service for physicians called Doximity. The service is a physician's private network (like Sermo?) and iPhone app designed to help physicians save time. (Always a good pitch for that group.) Doxmity aims to be the gold standard national directory of...
By Brian Dolan July 19, 2010
Earlier this year at the HIMSS event, Epocrates announced its plans to offer an affordable, easy to implement electronic health record specifically for the solo practitioner or small physician group. At the time it was a bit of an open secret that Epocrates had acquired some of Caretools' iChart assets since Epocrates named Dr. Tom Giannulli an "essential member of the Epocrates EHR development...
By Brian Dolan July 19, 2010
Epocrates, a popular provider of mobile drug reference tools, has re-filed for an estimated $75 million initial public offering, that will see its shares traded on NASDAQ under the symbol EPOC. Epocrates plans to use proceeds from the IPO for working capital, research and development, sales and marketing and capital expenditures, according to a filing with the SEC. Epocrates filed similar $75...